Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

dc.creatorNicol, Thomas
dc.creatorLefeuvre, Caroline
dc.creatorSerri, Orianne
dc.creatorPivert, Adeline
dc.creatorJoubaud, Françoise
dc.creatorDubée, Vincent
dc.creatorKouatchet, Achille
dc.creatorDucancelle, Alexandra
dc.creatorLunel-Fabiani, Françoise
dc.creatorLe Guillou-Guillemette, Hélène
dc.date.accessioned2020-07-27T22:11:50Z
dc.date.accessioned2022-09-23T18:11:59Z
dc.date.available2020-07-27T22:11:50Z
dc.date.available2022-09-23T18:11:59Z
dc.date.created2020-07-27T22:11:50Z
dc.identifier1386-6532
dc.identifierhttps://www.sciencedirect.com/science/article/pii/S1386653220302535?via%3Dihub
dc.identifierhttp://hdl.handle.net/20.500.12010/11248
dc.identifierhttps://doi.org/10.1016/j.jcv.2020.104511
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3497202
dc.publisherJournal of Clinical Virology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectInmunoensayos automatizados
dc.titleAssessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)


Este ítem pertenece a la siguiente institución